Safety, Distribution, and Pharmacokinetics of Biodegradable P( AAm ‐co‐ MAA ) Nanogels Following Systemic Administration in Mice
Journal of Biomedical Materials Research Part A · 2026-04 · 114 (4)
DOI: 10.1002/jbm.a.70072 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, online erschienen am 23.03.2026. Verfasst von Rana Ajeeb und 4 weiteren Autor:innen. Beteiligte Einrichtung: Stephenson School of Biomedical Engineering, The University of Oklahoma, Norman, Oklahoma, USA. Hauptthemen laut MEDLINE: Polyethylene Glycols, Polyethyleneimine, Polymethacrylic Acids, Biocompatible Materials. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, NIGMS NIH HHS, Harold Hamm Foundation.
Abstract (Originalsprache)
Systematic analysis of the fate of hydrogel nanoparticles after in vivo administration is essential for their clinical translation. Biodegradable, disulfide‐crosslinked synthetic nanogels are a promising platform for the delivery of therapeutic molecules, but their biodistribution and clearance profiles remain underexplored compared to other solid nanoparticles. In this study, we investigated the safety, pharmacokinetics, tissue, and cellular distribution profiles of poly(acrylamide‐co‐methacrylic acid) (P(AAm‐co‐MAA)) nanogels following a single intravenous or intraperitoneal injection. The nanogels exhibited rapid clearance from plasma, followed by early distribution primarily to the kidneys, liver, and small intestine. Within the liver, the nanogels showed preferential uptake by endothelial cells and resident macrophages. We further revealed organ‐specific differences in nanogel retention and clearance, with highly perfused organs demonstrating parallel clearance behavior with plasma, while organs such as the kidneys and small intestine served as sites of longer nanogel retention. Single injections of P(AAm‐co‐MAA) nanogel suspension did not induce any systemic innate immune activation nor organ‐specific toxicity, demonstrating a promising safety profile. These findings provide new insights into the in vivo behavior of redox‐responsive nanogels and provide a framework for their rational design and clinical translation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Stephenson School of Biomedical Engineering, The University of Oklahoma, Norman, Oklahoma, USA.
- Department of Neurosurgery, The University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA.
- Stephenson Cancer Center, The University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA.
- Harold Hamm Diabetes Center, The University of Oklahoma Health Campus, Oklahoma City, Oklahoma, USA.
- Institute for Biomedical Engineering, Science and Technology (IBEST), The University of Oklahoma, Norman, Oklahoma, USA.
ORCID-Profile: John R Clegg
Förderung
- NIH HHS
- NIGMS NIH HHS
- Harold Hamm Foundation
- Stephenson Cancer Center
- Office of the Vice President for Research and Partnerships
- Harold Hamm Diabetes Center
- NCI NIH HHS
- National Institutes of Health
Zitieren
APA
Ajeeb, R., Joshi, H., Ghanbari Mehrabani, M., Pierce, C., & Clegg, J. R. (2026). Safety, Distribution, and Pharmacokinetics of Biodegradable P( AAm ‐co‐ MAA ) Nanogels Following Systemic Administration in Mice. Journal of Biomedical Materials Research Part A, 114(4). https://doi.org/10.1002/jbm.a.70072
Vancouver
Ajeeb R, Joshi H, Ghanbari Mehrabani M, Pierce C, Clegg JR. Safety, Distribution, and Pharmacokinetics of Biodegradable P( AAm ‐co‐ MAA ) Nanogels Following Systemic Administration in Mice. Journal of Biomedical Materials Research Part A. 2026;114(4). doi:10.1002/jbm.a.70072
BibTeX
@article{Ajeeb2026,
author = {Ajeeb, Rana and Joshi, Harsh and Ghanbari Mehrabani, Mojtaba and Pierce, Christopher and Clegg, John R},
title = {Safety, Distribution, and Pharmacokinetics of Biodegradable P( AAm ‐co‐ MAA ) Nanogels Following Systemic Administration in Mice},
journal = {Journal of Biomedical Materials Research Part A},
year = {2026},
volume = {114},
number = {4},
doi = {10.1002/jbm.a.70072}
}
EUVIMED